351 related articles for article (PubMed ID: 25511568)
21. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells.
Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK
Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle.
Singh SP; Sharma M; Gupta PK
Lasers Med Sci; 2014 Mar; 29(2):645-52. PubMed ID: 23807180
[TBL] [Abstract][Full Text] [Related]
24. Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis.
Chen YN; Hsu SL; Liao MY; Liu YT; Lai CH; Chen JF; Nguyen MT; Su YH; Chen ST; Wu LC
Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28029125
[TBL] [Abstract][Full Text] [Related]
25. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
[TBL] [Abstract][Full Text] [Related]
26. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
28. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of intravenously injectable curcumin nanosuspension.
Gao Y; Li Z; Sun M; Guo C; Yu A; Xi Y; Cui J; Lou H; Zhai G
Drug Deliv; 2011 Feb; 18(2):131-42. PubMed ID: 20939679
[TBL] [Abstract][Full Text] [Related]
30. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronan degrading silica nanoparticles for skin cancer therapy.
Scodeller P; Catalano PN; Salguero N; Duran H; Wolosiuk A; Soler-Illia GJ
Nanoscale; 2013 Oct; 5(20):9690-8. PubMed ID: 23969526
[TBL] [Abstract][Full Text] [Related]
32. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
33. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
34. The effect of the molecular weight of hyaluronic acid on the physicochemical characterization of hyaluronic acid-curcumin conjugates and in vitro evaluation in glioma cells.
Tian C; Asghar S; Xu Y; Chen Z; Zhang M; Huang L; Ye J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 May; 165():45-55. PubMed ID: 29453085
[TBL] [Abstract][Full Text] [Related]
35. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.
Wang W; Chen T; Xu H; Ren B; Cheng X; Qi R; Liu H; Wang Y; Yan L; Chen S; Yang Q; Chen C
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966245
[TBL] [Abstract][Full Text] [Related]
36. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
Jiang H; Shi X; Yu X; He X; An Y; Lu H
Pharm Res; 2018 Feb; 35(4):73. PubMed ID: 29476264
[TBL] [Abstract][Full Text] [Related]
38. Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo.
Yang X; Li Z; Wang N; Li L; Song L; He T; Sun L; Wang Z; Wu Q; Luo N; Yi C; Gong C
Sci Rep; 2015 May; 5():10322. PubMed ID: 25980982
[TBL] [Abstract][Full Text] [Related]
39. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.
Negi LM; Jaggi M; Joshi V; Ronodip K; Talegaonkar S
Int J Biol Macromol; 2015 Feb; 73():222-35. PubMed ID: 25478964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]